Monkey study could lead to new Parkinson’s therapies

News

Author: Simge Eva DoganPublished: 13 September 2018

Prep: Cook: Serves:

Scientists at the Texas Biomedical Research Institute, US, are using marmosets – a small monkey species that can mimic the motor and non-motor symptoms of Parkinson’s – to better understand brain changes caused by the condition.

The study – published in science journal ‘PLOS ONE’ – induced the monkeys with Parkinson’s motor symptoms such as tremors and used devices similar to Fitbits to monitor their activities.

Researchers hope that further analysis will lead to new therapies for people living with the condition.

Marcel Daadi, associate scientist at the Texas Biomedical Research Institute and lead author of the study, said: “There are some complex aspects of this disease you simply cannot investigate using rodents in a way that is relevant to human patients.

“Nonhuman primates are critical in [this] aspect because we can see these symptoms clearly whether it is the dyskinesia (abnormality or impairment of voluntary movements), or the sleep disturbances that you can monitor.”

To read more on this topic click here.

For information on the latest Parkinson’s research please visit the EPDA website.

Last Month

Next Month

Go Back

Share this story

Comments

Perspectives

Why I promise to make poetry, not Parkinson’s disease, my daily challenge

Parkinson’s poet crafts a piece per day for year-long project

Parkinson’s podcast: ‘Parkinson’s Plus’ conditions

A look at the rare conditions often mistaken for Parkinson’s

Podcast: How can you speak the same language as your healthcare professional?

Physiotherapist Josefa Domingos opens up with her patient Idelta Oliveira

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

Researchers have discovered that a molecule called BT13 could have potential to treat Parkinson’s. The study, conducted by scientists from the University of Helsinki, Finland, found that mice injected with the BT13 molecule had an increase in dopamine levels in the brain. Their findings also suggested that the molecule could lead to a new drug treatment to protect the brain cells that produce dopamine. Dopamine helps coordinate movement, but people with Parkinson’s have normally lost between 70 and 80% of the brain cells that produce the neurotransmitter when they are diagnosed with the condition. Professor David Dexter, Deputy Director of Research at Parkinson’s UK – which co-funded the study – said: “People with Parkinson’s desperately need a new treatment that can stop the condition in its tracks, instead of just masking the symptoms. “More research is needed to turn BT13 into a treatment to be tested in clinical trials, to…

Students develop wearable device to track Parkinson’s tremors

A wearable device has been developed to monitor Parkinson’s tremors and their severity through the tracking of body movements. The device – Tremor Tracker – was created by two students, Julie Gaudin and Elizabeth Hummel, at Louisiana Tech University, US, as part of a design class project. The students designed an algorithm using data recorded from volunteer participants at Rock Steady, a boxing programme for people with Parkinson’s. They then applied the algorithm to a GENEActiv, a wrist-worn device that has been scientifically validated for clinical research. Hummel, co-creator of the Tremor Tracker, said: “Through supervised machine learning, the device predicts whether a patient’s tremors are parkinsonian or non-parkinsonian, as well as the severity of these tremors. A quantitative analysis of parkinsonian tremors provides a more detailed disease state.”

Can awakening dormant neurons reverse Parkinson’s motor symptoms?

Reawakening dormant neurons could help reverse Parkinson’s motor symptoms, researchers in South Korea have found. While Parkinson’s is typically believed to be caused by neuronal death, a new study – published in ‘Current Biology’ journal – suggests that dormant neurons could be another cause. After completing an animal test – which treated the subjects with two compounds that block dopamine-producing neurons from becoming dormant – the researchers found these neurons to be “awakened”, allowing them to resume dopamine production. The researchers hope that this will lead to a disease-modifying treatment, especially for people in the early stages of Parkinson’s. Hoon Ryu, a senior author of the study and researcher at KIST Brain Science Institute, South Korea, said: “This research refutes the common belief that there is no disease-modifying treatment for Parkinson’s due to its basis on neuronal cell death.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Name
This field is for validation purposes and should be left unchanged.

Monkey study could lead to new Parkinson’s therapies

News

Author: Simge Eva DoganPublished: 13 September 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Perspectives

Why I promise to make poetry, not Parkinson’s disease, my daily challenge

Resources & Tools

Parkinson’s podcast: ‘Parkinson’s Plus’ conditions

Episodes

Podcast: How can you speak the same language as your healthcare professional?

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

Students develop wearable device to track Parkinson’s tremors

Can awakening dormant neurons reverse Parkinson’s motor symptoms?

{title}

Subscribe

Monkey study could lead to new Parkinson’s therapies

News

Author: Simge Eva DoganPublished: 13 September 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Perspectives

Why I promise to make poetry, not Parkinson’s disease, my daily challenge

Resources & Tools

Parkinson’s podcast: ‘Parkinson’s Plus’ conditions

Episodes

Podcast: How can you speak the same language as your healthcare professional?

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

Students develop wearable device to track Parkinson’s tremors

Can awakening dormant neurons reverse Parkinson’s motor symptoms?

{title}

Subscribe

Sign in